Clinical Trial Update: Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the objective, prolonged effects of Restasis on dry eye disease; the study is completed and includes measurements of extended effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Restasis (Cyclosporine A)

Snippet

Sponsor: Innovative Medical | Conditions: Treatment of Dry Eye Disease | Phase 4 | Status: COMPLETED